NCT03941808View on ClinicalTrials.gov

Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

May 2, 2020

Study Completion Date

December 1, 2020

Conditions
Vitiligo
Interventions
DRUG

Glisodin tablet

4 pills a day (1000mg) for 3 months then 2 pills a day (500 mg) for 3 months

DRUG

Placebo tablet

4 pills a day (1000mg) for 3 months then 2 pills a day (500 mg) for 3 months

Trial Locations (1)

06001

Passeron, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT03941808 - Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. | Biotech Hunter | Biotech Hunter